Discover how next-generation capsule technologies, including Capsugel(R) Enprotect(R) capsules, are advancing targeted oral drug delivery, improving bioavailability,…
Pre-clinical studies are essential for evaluating the safety, pharmacokinetics, and efficacy of drug candidates before entering human trials.
This expert-led session explores the latest advancements in oral delivery systems for emerging drug modalities, with a particular focus on peptides and other complex…
Poster presentation delivered at the Controlled Release Society (CRS) Annual Meeting, 2025.
Explore how Lonza’s advanced polymer science and capsule manufacturing capabilities - Capsugel® Enprotect® - have led to a breakthrough in enteric protection.
Unlocking the full potential of many therapies hinges on effective absorption in the lower GI tract. Yet, delivering fragile APIs to the right location is no small…
The lower gastrointestinal tract is critical for enhancing bioavailability and drug absorption, directly influencing therapeutic efficacy.
Enteric capsules have many applications. Their principal purpose is to prevent the release of active pharmaceutical ingredients (APIs) in the stomach and to avoid…
The lower GI tract plays an important role in how well drugs are absorbed and utilized by the body. But delivering sensitive APIs to this region—especially those…
The lower gastro-intestinal tract plays an important role in optimizing bio-availability and drug absorption – and therefore the effectiveness of many therapies. But…
These findings confirm that Capsugel® Enprotect® capsules offer a robust, scalable, & patient-friendly alternative to traditional double-encapsulation methods
This downloadable summary features findings from a peer-reviewed study evaluating the in vivo performance of Capsugel® Enprotect® capsules
Delve contrasts between traditional coating methods with newer bi-layered polymer technologies, such as those used in Capsugel® Enprotect® capsules
Discover how Capsugel® Enprotect® capsule’s bi-layered polymer technology enables targeted enteric delivery—without the need for post-filling coating.
This Product Specification Brochure provides an overview of the Capsugel® Enprotect® capsule. It details the capsule’s composition, performance, data on dissolution,…
Capsugel® Enprotect® is a ready-to-use enteric capsule with acid resistance up to pH 6.0, eliminating the need for post-filling coating. This scientific brochure…
This study proposes an innovative and scalable solution to increase oral bioavailability of therapeutic peptides
  • 1 (current)
  • 2
Contact Us